Scientists at Virginia Tech have found a promising new treatment against cancer. The results of the study were published in the journal Cancer Discovery. “lenta.ru”.
According to scientists, the drug called MRTX1719 targets cancer cells with genetic changes that lack the CDKN2A tumor suppressor gene and MTAP gene. These mutations can allow cells to grow uncontrollably, but MRTX1719 exploits this weakness to eliminate cancer.
During trials, scientists were able to show positive results in patients with certain types of cancer, including melanoma, gallbladder cancer, mesothelioma and lung cancer.
On October 19, it was reported that scientists from the University of Pittsburgh had successfully performed it. tested an anti-cancer drug that stimulates the immune system to fight tumors in two different ways: 34% of patients with resistant tumors responded to the treatment.
Before that, American scientists from the University of Texas at Austin developed PEG-MTAP biological product that restores the immune system’s ability to fight cancer.
On October 12, scientists from Saratov developed An innovative antitumor drug based on Avran officinalis for the treatment of late stages of cancer.
Previous scientists to create New biomarkers of longevity in the blood of 100-year-olds.